ECTE - Echo Therapeutics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5180.06k
Enterprise Value 33.53M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.68

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2015
Most Recent Quarter (mrq)Sep 30, 2016
Profit Margin 0.00%
Operating Margin (ttm)0.00%
Management Effectiveness
Return on Assets (ttm)-359.77%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-12.5M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)172.72k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)3.52M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)N/A
Cash Flow Statement
Operating Cash Flow (ttm)-4.82M
Levered Free Cash Flow (ttm)-910.41k

Trading Information

Stock Price History
Beta 0.95
52-Week Change 3-95.95%
S&P500 52-Week Change 319.70%
52 Week High 30.450
52 Week Low 30.010
50-Day Moving Average 30.031
200-Day Moving Average 30.047
Share Statistics
Avg Vol (3 month) 316.18k
Avg Vol (10 day) 311.17k
Shares Outstanding 512M
Float 10.83M
% Held by Insiders 19.18%
% Held by Institutions 10.00%
Shares Short 3273.27k
Short Ratio 33.4
Short % of Float 32.40%
Shares Short (prior month) 3170.84k
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jun 7, 2013